Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Tiopronin products20.15M48.70%
FILSPARI19.83M47.94%
License and collaboration revenue1.39M3.36%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States145.24M100.00%